NOVATO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Cyclarity Therapeutics is pleased to announce regulatory approval to begin its first-in-human…
BOSTON, MASSACHUSETTS, Jan. 07, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing…
Over 300 Participants Have Completed Cumulative Six Months of Cytisinicline Treatment in the ORCA-OL Trial, Completing the Long-Term Exposure Requirement…
* Patients in Study Reported Lower Pain Levels, Better Sleep Quality, and Improved Wellbeing * Disease Activity Score Decreased by 19.2%,…
• Second regulatory designation for Restem-L, a lead ULSC program, following the recent Orphan Drug Designation• Recently reported Phase 1…
PRINCETON, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) formerly Acasti Pharma Inc. (Nasdaq: ACST) (Grace…
Breakthrough Therapy Designation granted based on key positive data from the Phase 2b (RIZE) study and current unmet medical need…
Research highlights need to expand PLD eligibility criteria to reflect real world data LOS ANGELES, Jan. 7, 2025 /PRNewswire/ -- Real-world…
JERUSALEM, Jan. 7, 2025 /PRNewswire/ -- Senseera, a liquid biopsy company pioneering chromatin epigenomics, announced the successful close of a…
The Intuitive Smart Ring Challenging Oura and Galaxy RingGenerative Sleep Aid Sound Enhancing Beyond Biometrics MeasurementLAS VEGAS, Jan. 6, 2025…